Company page

Spyglass Pharma, Inc.

Spyglass Pharma, Inc. is a public company traded under the ticker SGP in the American market. With a market capitalization of approximately $685 million, Spyglass Pharma focuses on developing innovative pharmaceutical solutions. The company is committed to advancing healthcare through its research and development efforts.

SGP:NASDAQUpdated September 12, 2026
Spyglass Pharma, Inc. logo
Ticker
SGP:NASDAQ
Asset type
Stock
Market cap
$920.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD